Search

Your search keyword '"van Gassen, Koen L.I."' showing total 105 results

Search Constraints

Start Over You searched for: Author "van Gassen, Koen L.I." Remove constraint Author: "van Gassen, Koen L.I."
105 results on '"van Gassen, Koen L.I."'

Search Results

1. Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations

2. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

3. Etiological involvement of KCND1 variants in an X-linked neurodevelopmental disorder with variable expressivity

4. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

5. Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

6. Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations

7. Unveiling the crucial neuronal role of the proteasomal ATPase subunit genePSMC5in neurodevelopmental proteasomopathies

8. De novo missense variants in phosphatidylinositol kinase PIP5KIγ underlie a neurodevelopmental syndrome associated with altered phosphoinositide signaling

10. Correction: Aminoacyl-tRNA synthetase deficiencies in search of common themes

11. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability

12. Correction to:De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy (Genetics in Medicine, (2021), 23, 4, (653-660), 10.1038/s41436-020-01020-w)

13. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

14. Characterization of SETD1A haploinsufficiency in humans and Drosophila defines a novel neurodevelopmental syndrome

15. Correction to: De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy

16. De novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy

17. Cross-omics: Integrating genomics with metabolomics in clinical diagnostics

18. De novo coding variants in the AGO1 gene cause a neurodevelopmental disorder with intellectual disability

19. Disruption of RFX family transcription factors causes autism, attention deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior

22. Expanding the Spectrum of BAF-Related Disorders : De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

23. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

24. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

25. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

26. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

27. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

28. De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia

29. De Novo Variants Disturbing the Transactivation Capacity of POU3F3 Cause a Characteristic Neurodevelopmental Disorder

30. Aminoacyl-tRNA synthetase deficiencies in search of common themes

31. Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3

32. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

33. Bi-allelic mutations in TRAPPC2L result in a neurodevelopmental disorder and have an impact on RAB11 in fibroblasts

34. Bi-allelic mutations in TRAPPC2L result in a neurodevelopmental disorder and have an impact on RAB11 in fibroblasts

36. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features

37. Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability

38. De novo variants in SNAP25cause an early-onset developmental and epileptic encephalopathy

39. Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control

40. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability

41. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

42. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features

43. Germline mutations affecting the histone H4 core cause a developmental syndrome by altering DNA damage response and cell cycle control

44. MCM3AP in recessive Charcot-Marie-Tooth neuropathy and mild intellectual disability

45. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

46. Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability

47. WDR26 Haploinsufficiency Causes a Recognizable Syndrome of Intellectual Disability, Seizures, Abnormal Gait, and Distinctive Facial Features

48. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features

49. De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability

50. De Novo Mutations in YWHAG Cause Early-Onset Epilepsy

Catalog

Books, media, physical & digital resources